scholarly journals Clinical Assessment for Attention Test in adult with Attention-Deficit/Hyperactivity Disorder for Evaluation of symptoms and medication effects

2020 ◽  
Vol 11 (0) ◽  
pp. 35-42
Author(s):  
Kentaro Kawabe ◽  
Fumie Horiuchi ◽  
Kiwamu Nakachi ◽  
Rie Hosokawa ◽  
Shu-ichi Ueno
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Clinical Assessment ◽  
Attention Deficit ◽  
Hyperactivity Disorder ◽  
Medication Effects

Subtypes of Aggression in Children with Attention Deficit Hyperactivity Disorder: Medication Effects and Comparison with Typical Children

2009 ◽  
Vol 38 (5) ◽  
pp. 619-629 ◽  
Author(s):  
Sara King ◽  
Daniel A. Waschbusch ◽  
William E. Pelham ◽  
Bradley W. Frankland ◽  
Penny V. Corkum ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Hyperactivity Disorder ◽  
Medication Effects

Medication Effects on EEG Biomarkers in Attention-Deficit/Hyperactivity Disorder

2016 ◽  
Vol 48 (4) ◽  
pp. 246-250 ◽  
Author(s):  
Havva Nuket Isiten ◽  
Merve Cebi ◽  
Bernis Sutcubasi Kaya ◽  
Baris Metin ◽  
Nevzat Tarhan
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Clinical Status ◽  
Quantitative Eeg ◽  
Theta Power ◽  
Hyperactivity Disorder ◽  
Medication Effects ◽  
Beta Power ◽  
Before And After ◽  
Medication Status

EEG biomarkers have become increasingly used to aid in diagnosis of attention-deficit/hyperactivity disorder (ADHD). Despite several studies suggesting that EEG theta/beta ratio may help discriminating ADHD from other disorders, the effect of medications on theta/beta ratio is not known. Forty-three children with ADHD that were evaluated with quantitative EEG before and after methylphenidate were included in the study. Theta/beta ratio, theta and beta powers for whole brain, central, and frontal areas were calculated. Theta/beta power decreased significantly after treatment; however, this change was largely due to an increase in beta power, rather than a fall in theta power. The results suggest that beta power is sensitive to medication effects, while theta power remains as a trait biomarker unaffected by medication status. The value of EEG biomarkers for monitoring neuropsychological performance and clinical status should be explored by future studies.

Oxford Textbook of Attention Deficit Hyperactivity Disorder

2018 ◽  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Clinical Assessment ◽  
Attention Deficit ◽  
Clinical Management ◽  
Best Practice ◽  
Clinical Presentation ◽  
Hyperactivity Disorder ◽  
Dsm 5 ◽  
Key Topics

The Oxford Textbook of Attention Deficit Hyperactivity Disorder provides an authoritative, multidisciplinary text displaying the latest research developments in the diagnosis, assessment, and management of patients with ADHD. Organized into eight key sections, this textbook covers the aetiology, pathophysiology, epidemiology, clinical presentation, comorbidity, clinical assessment, and clinical management of ADHD. Individual chapters address key topics, such as the clinical assessment of ADHD in adults and different presentations of ADHD. They contain information on best practice, current diagnostic guidelines, including DSM-5 and ICD-11, and key up-to-date references for further reading.

Sign in / Sign up

Export Citation Format

Share Document